# A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

> **NCT00559845** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 56 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** 5-fluorouracil
- **DRUG:** Epidoxorubicin
- **DRUG:** Cyclophosphamide
- **DRUG:** Paclitaxel
- **BIOLOGICAL:** Bevacizumab

## Key facts

- **NCT ID:** NCT00559845
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2018-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559845, "A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00559845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*